Apixaban in End-stage Kidney Disease : A Pharmacokinetics Study

NCT03456648 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

24

Enrollment

OTHER

Sponsor class

Conditions

ESRD
Anticoagulant Toxicity

Interventions

DRUG: apixaban

Sponsor

Universitaire Ziekenhuizen KU Leuven

Collaborators

[object Object]